GMI Global Medical Investors Aktiengesellschaft
GMI Global Medical Investors Aktiengesellschaft: GMI AG strenghtens market position inside German healthcare market
GMI Global Medical Investors Aktiengesellschaft / Acquisition/Mergers & Acquisitions 01.03.2010 08:00 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. --------------------------------------------------------------------------- GMI Global Medical Investors AG Munich, March 1st, 2010 New GMI daughter implements the build-up of supporting medical therapy institutions for selected German Medical Fraternities for the treatment of planned prospective 200.000 chronically ill patients in Germany, providing for approximately up to 2.000 new jobs. In line with the already implemented and registered capital increase of GMI Global Medical Investors AG (GMI AG), IMP International Medical Partners GmbH & Co KG has been subject to a 100 % take-over by GMI AG. IMP GmbH & Co KG specializes on the acquisition of shareholdings of companies in the fields of marketing and distribution inside the new German healthcare market. Besides the new German Healthcare Brand 'BMT Bio Medizinisches Therapiezentrum' also the DMF Deutsche Medical Franchise GmbH & Co KG belongs to IMP GmbH & Co KG, now acquired by GMI AG. Inside the boundaries of the currently newly developing and re-structuring German healthcare market DMF GmbH & Co KG develops franchise- and distribution concepts and medical networks for the medical profession. Under the roof of the brand name BMT, DMF GmbH & Co KG is building up to 200 institutional BMT Bio Medizinisches Therapie Zentrum nationwide in the standardized BMT system, in service for the resident medical profession. Inside the BMT cooperating resident doctors can perform highly efficient and cutting edge quality therapies for public- and private healthcare patients, as well as self-paying patients, right at their doorstep. Usually a regular representative of the resident medical profession is not in the position to master the investment going along with the implementation of such modern medical installments. Suffering from governmental income cuts and rising costs, the resident doctor would have to risk high-level investments while facing the difficult challenge having to amortize the investment all by himself. The BMT Zentrum, equipped with such high-level technical standard, provides supporting therapies inside the medical treatment chain in the areas of Dermatology, Orthopedy, Rheumatism, illnesses in the area of Psychosomatic. Due to consolidation of therapies in one large BMT Centrum, healthcare system, patients and the resident medical profession profit from the resulting savings. While BMT professionally informs the market using integrative marketing, distribution and public relations activities, the cooperating resident doctors ensure the high-level medical quality standard in all BMT Centers. After the successful completion of the planned build up of app. 200 BMT Centers, up to 2,000 new jobs shall be provided for and app. 200.000 chronically ill patients annually shall be able to receive regular treatment, eliminating the current standard, where, due to absence of availability of adequate nationwide treatment possibilities, limited or no pointed support can be provided. About GMI Global Medical Investors AG: Founded in 2009, GMI Global Medical Investors AG is a listed investment company based in Munich, Germany. GMI AG's investments focus on the rapidly changing and growing international healthcare market. GMI AG invests in companies that are well positioned with marketable products and services, offering stable growth potential within the value chain in the primary healthcare market. To realize these actions GMI AG uses either own capital, or operates, depending upon demand and necessity, with individually tailor-made institutional and private investment pools, aiming specifically at the before mentioned targeted platform. The overall aim of GMI Global Medical Investors AG is the value increase of the participations on a strictly sustainable basis and a partnership limited in time. GMI AG operates on grounds of a realistically accessible and timely limited exit strategy. GMI AG has a share capital of 12,434 Million EUR at its disposal, divided up into 12,434 Million pieces of bearer common shares. Shares of GMI AG have been listed on the Frankfurt Stock Exchange (Open Market) since January 13, 2010 (ISIN DE000A1A6ZU5). GMI Global Medical Investors AG Contact: Frank Michael Gaw Theresienstrasse 40 80333 Munich -Germany- E-mail: info@gmi-ag.com Telephone: +49-89-52011464 Fax: +49-89-52011465 www.gmi-ag.com Important information: This communication is neither an offer to sell nor a request to make an offer to sell securities in Germany and is not an offering prospectus within the meaning of the Wertpapierprospektgesetz (German Securities Offering Prospectus Act), the EU directive by the Commission No. 809/2004 dated April 29, 2005 or other legal provisions which apply in Germany which regulate the issue, the offering and the sale of securities. The information included in this announcement is not designated for dissemination to the United States of America or within the United States of America. The information included in this announcement is not for publication nor for dissemination in Canada, Australia or Japan, and does not constitute an offer for the purchase of securities in these countries. The placement of shares and the distribution of this announcement and other information in connection with the placement in certain legislative jurisdictions can be subject to statutory restrictions and those persons who gain possession of the documents named in this announcement should obtain their own information on all such restrictions and uphold these. Any failure to uphold these restrictions can constitute a violation of securities trading acts in the respective legislative jurisdictions. 01.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden